Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Irritable Bowel Syndrome, August 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 100 articles: HTML format

Single Articles

1. TAN D, Anderson B, Kesick A, Parker J, et al
   Irritable Bowel Syndrome and Periprosthetic Joint Infection Risk Following Total Hip and Knee Arthroplasty.
   J Arthroplasty. 2026 Jul 31:S0883-5403(26)00817.
   PubMed    
   Abstract available
   
   

2. ALSADAE NAO
   The mediating role of psychological flexibility in the relationship between mental alertness and mental health among patients with irritable bowel syndrome.
   Psychol Health Med. 2026 Jul 30:1-11. doi: 10.1080/13548506.2026.2710904.
   PubMed    
   Abstract available
   
   

3. STALLER K, Goodory VC, Ng CE, Ford AC, et al
   Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome V versus Rome IV Criteria.
   Clin Gastroenterol Hepatol. 2026 Jul 30:S1542-3565(26)00563.
   PubMed    
   Abstract available
   
   

4. RAJINDRAJITH S, Devanarayana N, Hathagoda W, Benninga M, et al
   Rome V criteria for pediatric disorders of gut - brain interaction: key updates and clinical implications.
   Expert Rev Gastroenterol Hepatol. 2026.
   PubMed    
   Abstract available
   
   

5. ARMSTRONG J, Morley S, Utter J
   Development and Acceptability of a Dietitian Delivered Patient Educational Video for Managing Irritable Bowel Syndrome.
   Am J Lifestyle Med. 2026 Jul 28:15598276261472814.
   PubMed    
   Abstract available
   
   

6. SJOBLOM K, Bellander M, Nilbrink J, Zetterqvist M, et al
   Randomised superiority trial evaluating an online transdiagnostic emotion regulation treatment for adolescents with mental health conditions: study protocol.
   BMJ Open. 2026;16:e116511.
   PubMed    
   Abstract available
   
   

7. WANG J, Duan G, Sun H, Dong Z, et al
   An Anterior Cingulate Cortex-Anterior Insular Cortex Glutamatergic Circuit Gates Stress-Induced Visceral Hypersensitivity and Anxiety via Ionotropic Glutamate Receptors Trafficking.
   Adv Sci (Weinh). 2026 Jul 29:e76298. doi: 10.1002/advs.76298.
   PubMed    
   Abstract available
   
   

8. SJOLUND J, Hreinsson JP, Lacy BE, Tornblom H, et al
   Global Prevalence of Self-Reported Alarm Features in the General Population and Among Individuals With Disorders of Gut-Brain Interaction-Results From the Rome Foundation Global Epidemiology Study.
   United European Gastroenterol J. 2026;14:e70269.
   PubMed    
   Abstract available
   
   

9. KERREBIJN I, Bjornsdottir G, Arbabi K, Urpa L, et al
   The genetic architecture of fibromyalgia across 2.5 million individuals.
   Nat Med. 2026 Jul 28. doi: 10.1038/s41591-026-04492.
   PubMed    
   Abstract available
   
   

10. LI T, Chen W, Bai L, Zhang S, et al
    Resveratrol ameliorates PM(2.5)-aggravated IBS-D mouse symptoms by restoring the gut bacteria and hypoxanthine/linoleic acid metabolism homeostasis.
    Environ Toxicol Pharmacol. 2026;126:105120.
    PubMed    
    Abstract available
    
    

11. HERNANDEZ MH, Lassale C, Camps-Vilaro A, Fernandez-Sanles A, et al
    Sleep-Related and Chronobiology Traits and Health-Related Phenotypes: A Phenome-Wide Mendelian Randomisation Study.
    J Sleep Res. 2026 Jul 28:e70411. doi: 10.1111/jsr.70411.
    PubMed    
    Abstract available
    
    

12. HASSAN W, Mayhew AJ, Sohel N, Killian KJ, et al
    Prevalence and risk factors for refractory and untreated chronic cough in the Canadian Longitudinal Study of Aging.
    ERJ Open Res. 2026;12:01659-2025.
    PubMed    
    Abstract available
    
    

13. DEMIR E, Ozalp YC, Ergun HB, Uludag B, et al
    The Effect of a Low-FODMAP Diet on Quality of Life, Severity of Symptoms and Leaky Gut in Patients with Irritable Bowel Syndrome.
    Nutrients. 2026;18:2371.
    PubMed    
    Abstract available
    
    

14. BORRUEL SAINZ N, Serra-Ruiz X, Guarner Aguilar F, Castiglione F, et al
    VSL#3((R)) May Reduce Abdominal Pain and Bloating in Ulcerative Colitis Remission with IBS-like Symptoms: An Exploratory Randomized, Double-Blind Placebo-Controlled Trial.
    Nutrients. 2026;18:2257.
    PubMed    
    Abstract available
    
    

15. MARGINEAN IC, Cazacu SM, Marginean CM, Popescu M, et al
    Is MASLD Not Just a Liver Disease? Bidirectional Gut-Liver Crosstalk as a Driver of Chronic Liver Disease.
    Life (Basel). 2026;16:1076.
    PubMed    
    Abstract available
    
    

16. RA J, Rao S, Ramdass PVAK
    Cholecystectomy and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 3,511,681 Patients.
    J Clin Med. 2026;15:5392.
    PubMed    
    Abstract available
    
    

17. MOHAMMED A, Baig Y, Butler AE
    Faecal Calprotectin: A Non-Invasive Marker for Diagnosing and Monitoring Acute Diverticulitis.
    Med Sci (Basel). 2026;14:406.
    PubMed    
    Abstract available
    
    

18. EL-SALHY M, Skarvatun T, Hoff DAL, Lunding J, et al
    Possible Mechanisms Underlying the Effects of Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2026;32:449-463.
    PubMed    
    Abstract available
    
    

19. BUSHYHEAD D, Khatun R, Bangdiwala SI, Palsson O, et al
    The Association Between Usual Diet and Bowel Disorders of Gut-Brain Interaction: Analyses From the Rome Foundation Global Epidemiology Study.
    J Neurogastroenterol Motil. 2026;32:429-437.
    PubMed    
    Abstract available
    
    

20. MARTIN LD, Fragkos KC
    The Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet Is Effective in Irritable Bowel Syndrome With Constipation: A Single Center Tertiary Care Clinical Practice Evaluation.
    J Neurogastroenterol Motil. 2026;32:396-404.
    PubMed    
    Abstract available
    
    

21. SIAH KTH, Freud T, Zhang VRY, Sperber AD, et al
    Disorders of Gut-Brain Interaction and Psychological Comorbidity in Singapore: Insights From the Rome IV Global Epidemiology Study.
    J Neurogastroenterol Motil. 2026;32:372-386.
    PubMed    
    Abstract available
    
    

22. KIM YS, Choi SC
    Beyond Dysbiosis Restoration: Does the Success of Fecal Microbiota Transplantation for Irritable Bowel Syndrome Lie in Repairing the Intestinal Stem Cell Niche?
    J Neurogastroenterol Motil. 2026;32:307-309.
    PubMed    
    
    
    

23. DIAZ FERNANDEZ W, Salolin Vargas VP, Padilla-Zambrano HS, Cerino-Penaloza MS, et al
    [Microbiome-Gut-Brain Axis in Irritable Bowel Syndrome: Pathophysiology and Therapeutic Approaches].
    Rev Gastroenterol Peru. 2026;46:175-187.
    PubMed    
    Abstract available
    
    

24. URREGO JA, Marulanda H, Frias JS, Cedron H, et al
    [Irritable bowel syndrome: an organic disease].
    Rev Gastroenterol Peru. 2026;46:159-174.
    PubMed    
    Abstract available
    
    

25. N V, Rout S, P V
    Restoring gut harmony - Role of Grahani Chikitsa in the management of irritable bowel syndrome - a case report.
    J Ayurveda Integr Med. 2026;17:101386.
    PubMed    
    Abstract available
    
    

26. YU Q, Xu B, Dai C, Pang Y, et al
    Investigation of the Mechanism of Cinnamaldehyde in Irritable Bowel Syndrome Based via Network Pharmacology, Molecular Docking, and Animal Experiments.
    Pediatr Discov. 2025 Oct 5:e70017. doi: 10.1002/pdi3.70017.
    PubMed    
    Abstract available
    
    

27. PROZIALECK JD, Potthoff LM, Whitehead B, Fortunato JE, et al
    Complementary and alternative medicine use by patients in pediatric gastroenterology clinics.
    JPGN Rep. 2026 Jun 30:10.1002/jpr3.70207. doi: 10.1002/jpr3.70207.
    PubMed    
    Abstract available
    
    

28. ZHOU Z, Liu L, Fu J, Yan H, et al
    Research status, hotspots, and frontiers in functional abdominal pain syndrome: A bibliometric and visual analysis.
    Medicine (Baltimore). 2026;105:e49899.
    PubMed    
    Abstract available
    
    

29. SARTORI L, Argomaniz N, Farsi DN, Bajka B, et al
    Almonds and Their Impact on Mental Health and the Gut-Brain Axis in Adults with Symptoms of Anxiety and Depression: A 12-Week Randomized Controlled Trial.
    J Nutr. 2026 Jul 16:101732. doi: 10.1016/j.tjnut.2026.101732.
    PubMed    
    Abstract available
    
    

30. CUI X, Wang H, Zhang H, Zhang X, et al
    Fecal microbiota profiling in patients with irritable bowel syndrome and small intestinal bacterial overgrowth.
    Medicine (Baltimore). 2026;105:e49955.
    PubMed    
    Abstract available
    
    

31. DHIMAN NK, Ahmad SR
    From Dysbiosis to systemic health: Microbiome modulation as a unified therapeutic framework.
    Acta Microbiol Immunol Hung. 2026 Aug 7:030.2026.03015.
    PubMed    
    Abstract available
    
    

32. QIU Y, Zhou Y, Liu S, Zhang Q, et al
    Long-term risk of incident psoriasis in patients with irritable bowel syndrome: a large-scale prospective cohort study.
    J Glob Health. 2026;16:04140.
    PubMed    
    Abstract available
    
    

33. WEINSTOCK L, Salt WB 2nd, Cherry L, Tyson C, et al
    A real-world assessment of healthcare resource utilization following IBS-Smart ((R)) and Trio-Smart ((R)) testing in patients with suspected irritable bowel syndrome.
    Front Gastroenterol (Lausanne). 2026;5:1681818.
    PubMed    
    Abstract available
    
    

34. MARTINSEN T, Jensen C, Hatlebakk JG, Valeur J, et al
    Gastrointestinal symptoms, faecal short-chain fatty acids and dietary intake in older adults: the Hordaland Health Study 3.
    Eur J Nutr. 2026;65:230.
    PubMed    
    Abstract available
    
    

35. BARASH L, Lindmoen C, Borlack RE
    What is new in abdominal pain-related disorders of the gut-brain interaction in children.
    Curr Opin Pediatr. 2026 Aug 6. doi: 10.1097/MOP.0000000000001597.
    PubMed    
    Abstract available
    
    

36. MO W, Cai F, Li L, Liang J, et al
    Mapping research trends in irritable bowel syndrome and the gut microbiome: a cross-database bibliometric analysis.
    Front Microbiol. 2026;17:1900159.
    PubMed    
    Abstract available
    
    

37. YAO Y, Li J, Zhang B, Li T, et al
    Unveiling the aging-immune axis in irritable bowel syndrome: a multi-omics and machine learning approach to biomarker discovery and validation.
    Front Immunol. 2026;17:1893702.
    PubMed    
    Abstract available
    
    

38. WHELAN K, Staudacher HM
    Dietary management of gastrointestinal disease: progress over the last decade and opportunities for the next.
    Lancet Gastroenterol Hepatol. 2026;11:738-741.
    PubMed    
    
    
    

39. THONGCHUENJIT S, Luo X, Yuan H, Li Q, et al
    Abdominal bloating frequency and clinical burden in irritable bowel syndrome classified using an operationalized Rome V algorithm.
    Rev Esp Enferm Dig. 2026 Aug 4. doi: 10.17235/reed.2026.12014/2026.
    PubMed    
    Abstract available
    
    

40. VAN DEN BELT M, JanssenDuijghuijsen L, Tomassen M, de Roos N, et al
    Impact of 3-day turmeric supplementation on fasting and postprandial LPS and chylomicron-related markers in patients with IBS: A randomized crossover trial.
    Br J Nutr. 2026 Aug 3:1-28. doi: 10.1017/S0007114526108101.
    PubMed    
    Abstract available
    
    

41. LEI Y, Liu Y
    Plasma proteins and irritable bowel syndrome: A proteome-wide Mendelian randomization study.
    Medicine (Baltimore). 2026;105:e50229.
    PubMed    
    Abstract available
    
    

42. TSAI FP, Chang LC, Yeh CC, Chen CC, et al
    Prevalence and clinical characteristics of irritable bowel syndrome in Taiwan: Rome III versus Rome IV criteria.
    J Formos Med Assoc. 2026 Aug 13:S0929-6646(26)00812.
    PubMed    
    Abstract available
    
    

43. SAINI U, Wanders R, Oldehinkel AJ, Rosmalen JGM, et al
    Data-driven subtypes of internalizing and functional somatic symptoms: A hybrid mixture modeling approach.
    Gen Hosp Psychiatry. 2026;102:170-178.
    PubMed    
    Abstract available
    
    

44. SENADHEERA P, Silva B, Jayasena H, Niriella M, et al
    Mistakes in the management of irritable bowel syndrome-diarrhoeal subtype and mimics: a narrative review.
    Curr Med Res Opin. 2026 Aug 13:1-20. doi: 10.1080/03007995.2026.2716974.
    PubMed    
    Abstract available
    
    

45. FOULKROD AM, Beltran TA, Ordway SM
    Characterization of Clostridioides difficile in the U.S. Military, 2016-2024.
    Mil Med. 2026 Aug 13:usag386. doi: 10.1093.
    PubMed    
    Abstract available
    
    

46. MUSTIKA S, Firdaus AF, Simamora AB, Hatinah AN, et al
    Decoding the gut-brain axis in irritable bowel syndrome: a cross-sectional analysis of anxiety and depression symptoms in constipation and diarrhoea predominant subtypes.
    Med Glas (Zenica). 2026;23.
    PubMed    
    Abstract available
    
    

47. DZIDIC-KRIVIC A, Dizdarevic B, Mesanovic A, Kusturica J, et al
    Irritable bowel syndrome-related symptoms among medical students in Bosnia and Herzegovina.
    Med Glas (Zenica). 2026;23.
    PubMed    
    Abstract available
    
    

48. CHEN J, Li A, Wu W, Xu W, et al
    Gut microbiota signatures differentiate trajectory-defined response phenotypes and predict self-management outcomes in irritable bowel syndrome.
    Front Microbiomes. 2026;5:1884540.
    PubMed    
    Abstract available
    
    

49. HYUNG SW, Park UJ, Ryu JH, Chung S, et al
    Glucagon-like Peptide-1 Receptor Agonists and Chronic Pain: Preclinical Antinociceptive Mechanisms, Indirect Metabolic-Functional Effects, and Clinical Considerations-A Narrative Review.
    J Clin Med. 2026;15:5932.
    PubMed    
    Abstract available
    
    

50. JORGENSEN T, Jacobsen RK, Jorgensen SW, Petersen MW, et al
    Insulin, Glucose and Lipid Biomarkers as Possible Risk Factors for Functional Somatic Disorder: A Five-Year Follow-Up of the DanFunD Cohort.
    J Clin Med. 2026;15:5793.
    PubMed    
    Abstract available
    
    

51. VALDISERRA G, Di Salvo C, Campigli L, D'Antongiovanni V, et al
    A Novel Mixture Containing Enterococcus lactis SF68((R)) Restores Gut Barrier Integrity in a DSS-Induced Murine Model of Post-Colitis IBS-like Symptoms.
    Int J Mol Sci. 2026;27:6629.
    PubMed    
    Abstract available
    
    

52. JEON HJ, Moon JS, Jeong HM, Bang WY, et al
    Heyndrickxia coagulans IDCC 1201 Alters Gut Microbiome and Metabolome in Patients with Functional Bowel Disorders.
    Nutrients. 2026;18:2466.
    PubMed    
    Abstract available
    
    

53. MANNING LP, Tuck CJ, Biesiekierski JR, Willcox JC, et al
    Exploring the Experiences and Expectations of a Structured Low Fermentable Oligo-, Di-, Monosaccharide and Polyol Diet in People with Irritable Bowel Syndrome: A Qualitative Investigation.
    J Acad Nutr Diet. 2026 Aug 12:156437. doi: 10.1016/j.jand.2026.156437.
    PubMed    
    Abstract available
    
    

54. STASKIEWICZ-BARTECKA W, Lewandowski P, Kolodziejczyk A, Kardas M, et al
    Frequency of FODMAP-rich products consumption and irritable bowel syndrome-like symptoms among amateur runners.
    Front Nutr. 2026;13:1888737.
    PubMed    
    Abstract available
    
    

55. LI K, Wang J, Zou L, Song X, et al
    Electroacupuncture-mediated lncRNA TUG1 regulates the miR-127-3p/NF-kappaB p65 axis to inhibit IBS-D low-grade intestinal inflammation.
    Front Immunol. 2026;17:1764684.
    PubMed    
    Abstract available
    
    

56. MAH E, McKenna CF, Blonquist TM, Kaden VN, et al
    Oral Fructanase Administration Reduces Gastrointestinal Symptom Severity After Acute Inulin Challenge in Healthy Adults.
    J Nutr. 2026 Aug 11:101782. doi: 10.1016/j.tjnut.2026.101782.
    PubMed    
    Abstract available
    
    

57. RAMAKRISHNA BS
    Tropical sprue: a forgotten entity.
    Curr Opin Infect Dis. 2026 Aug 6. doi: 10.1097/QCO.0000000000001227.
    PubMed    
    Abstract available
    
    

58. RAJABI N, Ramdass PVAK
    Association between myalgic encephalomyelitis/chronic fatigue syndrome and irritable bowel syndrome: a systematic review and meta-analysis.
    Front Med (Lausanne). 2026;13:1881784.
    PubMed    
    Abstract available
    
    

59. BABU SR, Mohtat A, Ho MF, Hayashi Y, et al
    Circadian regulation of gastrointestinal motility and the effect on disorders of gut-brain interaction.
    J Smooth Muscle Res. 2026;62:26-39.
    PubMed    
    Abstract available
    
    

60. MEYER A, Auer J, Cascant-Ortolano L, Schreiber N, et al
    Systematic Review and Meta-Analysis: Plant-Based Therapy for Irritable Bowel Syndrome.
    Phytother Res. 2026 Aug 9. doi: 10.1002/ptr.70421.
    PubMed    
    Abstract available
    
    

61. LIU A, Ai Y, Yang P, Zhang L, et al
    Candidalysin drives pyroptosis of intestinal epithelium to exacerbate IBS by suppressing HDAC2-mediated deacetylation of GSDMD-K194.
    J Adv Res. 2026 Aug 9:S2090-1232(26)00619-3. doi: 10.1016/j.jare.2026.
    PubMed    
    Abstract available
    
    

62. HACKSHAW KV
    Central sensitization syndromes as a neuropsychiatric risk state for dementia: Clinical and epidemiologic perspectives.
    CNS Spectr. 2026;31:e29.
    PubMed    
    Abstract available
    
    

63. UCAR M, Celebi D, Celebi O, Baser S, et al
    Investigation of the Effect of Akkermansia muciniphila Muc T (ATCC BAA-835) on TLR4/NF-Kappa B/NLRP2 Signaling Pathway and Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome in Rats.
    Probiotics Antimicrob Proteins. 2026 Aug 21. doi: 10.1007/s12602-026-11186.
    PubMed    
    Abstract available
    
    

64. MILEWSKI M
    Lymphocytic Microscopic Colitis Associated with Paroxetine: A Psychiatric Nursing Case Report.
    J Am Psychiatr Nurses Assoc. 2026 Aug 21:10783903261477364.
    PubMed    
    Abstract available
    
    

65. GOYAL MK, Brahmandam G, Chowdhary R, Subhasri Guna SD, et al
    Management of constipation: A narrative review of evolving strategies and methodological challenges.
    World J Methodol. 2026;16:118399.
    PubMed    
    Abstract available
    
    

66. CLARK A, Li R, Spiegel BMR, Almario CV, et al
    A Single Question on Quality-of-Life Improvement Identifies Treatment Satisfaction in Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2026 Aug 20:S1542-3565(26)00629.
    PubMed    
    
    
    

67. TUNALI V, Arslan NC, Dervis Haki?m G, Gundogdu A, et al
    Long-term microbiome and clinical effects of a microbiome-guided personalized diet versus low-FODMAP diet in irritable bowel syndrome: A 12-month follow-up randomized controlled trial.
    Gut Microbes. 2026;18:2719125.
    PubMed    
    Abstract available
    
    

68. WEI Y, Zhang H, Wang N, Jin H, et al
    Development and internal validation of a machine learning-based disease burden index for irritable bowel syndrome: a multicentre cross-sectional study.
    Ann Med. 2026;58:2721087.
    PubMed    
    Abstract available
    
    

69. GODAVARTHY P, Iyer MR, Munnavan R, Halhaturage TL, et al
    Comparative Analysis of Large Language Model Outputs for Pre-hypnotherapy Support in Irritable Bowel Syndrome - An Experimental Feasibility Study.
    J Neurogastroenterol Motil. 2026 Aug 20. doi: 10.5056/jnm25145.
    PubMed    
    Abstract available
    
    

70. SAYUK GS, Filipenko D, Kornalska K, Swinburn P, et al
    Assessing Treatment Response in Patients With IBS-C in Clinical Practice: Consensus Expert Recommendations Using a Modified Delphi Process.
    Clin Transl Gastroenterol. 2026 Aug 19. doi: 10.14309/ctg.0000000000001086.
    PubMed    
    Abstract available
    
    

71. SATO-NUMATA K, Takayama R, Sakai A, Numata T, et al
    Hange-Shashin-to Suppresses Serotonin-Induced Neurogenic Intestinal Contraction via Inhibition of 5-HT3A Receptor Signaling.
    Cell Physiol Biochem. 2026;60:427-444.
    PubMed    
    Abstract available
    
    

72. JIANG S, Ping C, He X, Chen G, et al
    NEAT1-Mediated Intestinal Barrier Dysfunction Through miR-29b-3p Binding in Lipopolysaccharide-Damaged Caco-2 Cells.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available
    
    

73. ALSHAMRANI AA
    A Computational Workflow for Prioritizing Microbial Metabolite-Associated Host Genes in Constipation-Predominant Irritable Bowel Syndrome.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available
    
    

74. ZHAO R, Xu H, Zhu Y, Chang H, et al
    Gut-Brain-Skin Axis: From Mechanistic Insights to Translational Applications in Neurocosmetics.
    Dermatol Ther (Heidelb). 2026 Aug 18. doi: 10.1007/s13555-026-01892.
    PubMed    
    Abstract available
    
    

75. GAU SY, Su YJ, Yang SC, Chen CC, et al
    Risk of systemic rheumatic diseases in people with irritable bowel syndrome: a global-federated cohort analysis.
    Front Immunol. 2026;17:1779191.
    PubMed    
    Abstract available
    
    

76. SOUZA PHSO, Coelho JRC, de Andrade AM, Marques KS, et al
    Low-FODMAP diet for pediatric patients with disorders of gut-brain interaction: A systematic review and meta-analysis.
    JPEN J Parenter Enteral Nutr. 2026 Aug 17. doi: 10.1002/jpen.70135.
    PubMed    
    Abstract available
    
    

77. 
    [Guidelines for the diagnosis, treatment, and management of irritable bowel syndrome in children (2026)].
    Zhonghua Er Ke Za Zhi. 2026;64:975-984.
    PubMed    
    
    
    

78. BUSAM JA, Pimentel M
    Endpoint discordance in IBS-C: Bloating as a partially uncaptured therapeutic signal.
    Clin Gastroenterol Hepatol. 2026 Aug 16:S1542-3565(26)00591.
    PubMed    
    
    
    

79. GOYAL MK, Goyal O, Chowdhary R, Sehgal T, et al
    Biomarkers in Irritable Bowel Syndrome: Bridging Gut-Brain Mechanisms to Precision Care.
    Curr Gastroenterol Rep. 2026;28:25.
    PubMed    
    Abstract available
    
    

80. JAVED A
    Letter: SCFA Enrichment in IBS-D-A Disease Subtype or a Transit-Driven Phenomenon?
    Aliment Pharmacol Ther. 2026 Jul 27. doi: 10.1111/apt.70891.
    PubMed    
    
    
    

81. CORSETTI M, Pandolfino JE, Rao SS, Tack J, et al
    What's New in Rome V.
    Am J Gastroenterol. 2026 Jul 31. doi: 10.14309/ajg.0000000000004169.
    PubMed    
    
    
    

82. KHAN SA, Marasini A, Shrestha A, Bharadwaj HR, et al
    Impact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis.
    Dig Dis Sci. 2026 Aug 8. doi: 10.1007/s10620-026-10171.
    PubMed    
    Abstract available
    
    

83. DONG G, Li A, Zeng H, Li X, et al
    Saikosaponin D Improves Diarrhea-Predominant Irritable Bowel Syndrome by Regulating the Brain-Gut Axis: Based on Changes in the Gut HMGB1-TLR4/NF-kappaB Pathway and Hypothalamic HPA Axis.
    Dig Dis Sci. 2026 Aug 6. doi: 10.1007/s10620-026-10165.
    PubMed    
    Abstract available
    
    

84. KAUR M, Poddar U, Srivastava A, Sarma MS, et al
    Randomized Placebo-Controlled Trial of Psyllium Fiber in Functional Abdominal Pain Disorders in Children.
    Dig Dis Sci. 2026 Aug 4. doi: 10.1007/s10620-026-10156.
    PubMed    
    Abstract available
    
    

85. DENG Y, Ao X, Liang X, Hao W, et al
    The Potential of Complementary and Alternative Therapies in Improving Diarrhea-Predominant Irritable Bowel Syndrome: Strategies for Long-Term Efficacy.
    Dig Dis Sci. 2026 Aug 12. doi: 10.1007/s10620-026-10134.
    PubMed    
    Abstract available
    
    

86. SIRAGUSA N, Costantino A, Baldassari G, Dell'Era A, et al
    Dietary modulation of transient receptor potential vanilloid 1 as a potential therapeutic target in irritable bowel syndrome and other disorders of gut-brain interaction.
    Eur J Gastroenterol Hepatol. 2026;38:1110-1111.
    PubMed    
    
    
    

87. LIU Z, Ma X
    Concern Regarding the Events-per-Variable Ratio in a Persistence Analysis of Irritable Bowel Syndrome.
    Gastroenterology. 2026 Jul 29:S0016-5085(26)07076.
    PubMed    
    
    
    

88. CHANG L, Bedell A, Smith J, Smith S, et al
    Gastro Grand Rounds:Managing Complex IBS: A Multidisciplinary, Mechanism-Based Approach.
    Gastroenterology. 2026 Aug 4:S0016-5085(26)07124.
    PubMed    
    
    
    

89. STAUDACHER HM, Rucco V, Mancell S, Dimidi E, et al
    Fiber supplementation in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Gastroenterology. 2026 Aug 14:S0016-5085(26)07147.
    PubMed    
    Abstract available
    
    

90. SNIJKERS JTW, Bosman MHMA, Winkens B, Haarhuis BJT, et al
    In-person therapist-delivered hypnotherapy versus smartphone-based self-guided hypnotherapy in IBS: a multicentre three-armed randomised controlled trial.
    Gut. 2026 Jul 25:gutjnl-2026-338385. doi: 10.1136/gutjnl-2026-338385.
    PubMed    
    Abstract available
    
    

91. KHASAWNEH M, Thakur ER, Goodoory VC, Moayyedi P, et al
    Letter in reply: should SNRIs be considered the most effective neuromodulators for IBS?
    Gut. 2026 Aug 5:gutjnl-2026-340150. doi: 10.1136/gutjnl-2026-340150.
    PubMed    
    
    
    

92. RIDZAL L, Frieling T, Roka R, Inczefi O, et al
    Faecal proteases and immune signatures drive subtype-specific enteric neuronal activation in IBS.
    Gut. 2026 Aug 4:gutjnl-2025-337949. doi: 10.1136/gutjnl-2025-337949.
    PubMed    
    Abstract available
    
    

93. ZHANG H, Fang Z, Jiang B
    Accessibility versus efficacy: interpreting the non-inferiority trial of digital hypnotherapy in IBS.
    Gut. 2026 Aug 19:gutjnl-2026-340199. doi: 10.1136/gutjnl-2026-340199.
    PubMed    
    
    
    

94. SPERBER AD, Hreinsson JP, Simren M, Drossman DA, et al
    Rome V global epidemiology and validation survey: prevalence of disorders of gut-brain interaction and comparison with the Rome IV global epidemiology study.
    Gut. 2026 Aug 18:gutjnl-2026-339666. doi: 10.1136/gutjnl-2026-339666.
    PubMed    
    Abstract available
    
    

95. NURKO S, Taft T, Palsson OS, Benninga M, et al
    Multinational prevalence and burden of paediatric disorders of gut-brain interaction: results of the Rome Foundation paediatric global study.
    Gut. 2026 Aug 18:gutjnl-2026-339667. doi: 10.1136/gutjnl-2026-339667.
    PubMed    
    Abstract available
    
    

96. NEO KML, How AL, Ang AYH, Pang GY, et al
    Cost-of-Illness of Irritable Bowel Syndrome: A Systematic Review.
    J Gastroenterol Hepatol. 2026 Jul 31. doi: 10.1111/jgh.70618.
    PubMed    
    Abstract available
    
    

97. CHENGJIAO Y, Zerui Z, Mengjun P, Liming L, et al
    Differences in the Plasma Bile Acid-Gut Microbiota Axis Between IBS-D and IBS-C.
    J Gastroenterol Hepatol. 2026 Aug 18. doi: 10.1111/jgh.70669.
    PubMed    
    Abstract available
    
    

98. ZHONG J, Xu Z, Chen W, Jiang Y, et al
    Consolidation Therapy of Probiotics With Rifaximin Prevent Relapse in Rifaximin-Responsive Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Randomized Clinical Trial.
    J Gastroenterol Hepatol. 2026 Aug 18. doi: 10.1111/jgh.70672.
    PubMed    
    Abstract available
    
    

99. VLIEGER AM, Snyder J, Nurko S, Benninga MA, et al
    Harnessing language in pediatric disorders of gut-brain interaction: A practical guide to suggestive communication.
    J Pediatr Gastroenterol Nutr. 2026 Jul 27. doi: 10.1002/jpn3.70520.
    PubMed    
    
    
    

100. HE X, Wang D, Yang B, Yan H, et al
     HIF-1alpha inhibits the TLR4/NF-kappaB signaling pathway and modulates intestinal flora in diarrhea-predominant irritable bowel syndrome.
     PLoS One. 2026;21:e0355467.
     PubMed    
     Abstract available